Search
for
Sort by
Research 31–60 of 869
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- Cicatricial (scarring) alopecia
- Atlas of Geriatric Dermatology
- Syphilis: A great imitator
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Can Artificial Intelligence “Hold” a Dermoscope?—The Evaluation of an Artificial Intelligence Chatbot to Translate the Dermoscopic Language
- Eruptive vellus hair cysts: An underdiagnosed entity
- Keloid scars arising after follicular unit extraction hair transplantation
- Cutaneous manifestations associated with substance use disorders
- Skin manifestations associated with systemic diseases – Part I
- Dermoscopy of annular elastolytic giant cell granuloma
- Inherited Disorders of the Hair
- Giant solitary trichoepithelioma: A rare trichogenic tumor
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Multiple minute digitate hyperkeratosis
- Pinnal Diseases
- Subject Index
- Cutaneous complications of chemotherapeutic agents
- Dermatological manifestations associated with pregnancy
- Tips for addressing common conditions affecting pediatric and adolescent patients with skin of color
- Diffuse loss of hair with papules
- Congenital Atrichia: A Case Report
- Combined autologous platelet-rich plasma with microneedling verses microneedling with distilled water in the treatment of atrophic acne scars: a concurrent split-face study
- Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- Dermatology for the elderly: An Indian perspective
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III